Chapdelaine; Marc
Patent Applications and Registrations
Patent applications and USPTO patent grants for Chapdelaine; Marc.The latest application filed is for "uses of cinnoline compounds to treat schizophrenia".
- Chapdelaine; Marc - Wilmington DE
| Patent | Date |
|---|---|
| Uses of cinnoline compounds to treat schizophrenia App 20100184738 - Arriza; Jeffery Louis ; et al. | 2010-07-22 |
| 2-(1-aza-bicyclo[2.2.2]oct-3-yl)-2,3-dihydro-isoindole-1-one/5,6-dihydro-f- uro[2,3-c] pyrrol-4-one derivative ligands for alpha 7 nicotinic acetylcholine receptor Grant 7,566,727 - Chapdelaine , et al. July 28, 2 | 2009-07-28 |
| Compounds and Uses Thereof - 849 App 20080318925 - Arriza; Jeffery Louis ; et al. | 2008-12-25 |
| Compounds and Uses Thereof - 848 App 20080318943 - Chang; Hui-Fang ; et al. | 2008-12-25 |
| Nicotinic Acetylcholine Receptor Ligands App 20080113983 - Chapdelaine; Marc ; et al. | 2008-05-15 |
| Therapeutic Heterocyclic Compounds 507 App 20080076759 - Pierson; Edward ; et al. | 2008-03-27 |
| N-type calcium channel antagonists for the treatment of pain Grant 7,348,340 - Chapdelaine , et al. March 25, 2 | 2008-03-25 |
| Therapeutic heterocyclic compounds Grant 7,285,662 - Pierson , et al. October 23, 2 | 2007-10-23 |
| Novel 2-(1-Aza-Bicyclo[2.2.2.]Oct-3-Yl)-2,3-Dihydro-Isoindole-1-One/5,6-Di- hydro-Furo[2,3-C] Pyrrol-4-One Derivative Ligands For Alpha 7 Nicotinic Acetylcholine Receptor App 20070213342 - Chapdelaine; Marc ; et al. | 2007-09-13 |
| N-type Calcium Channel Antagonists For The Treatment Of Pain App 20070129363 - Chapdelaine; Marc ; et al. | 2007-06-07 |
| N-type calcium channel antagonists for the treatment of pain Grant 7,189,714 - Chapdelaine , et al. March 13, 2 | 2007-03-13 |
| Therapeutic quinoline compounds App 20060178372 - Haeberlein; Markus ; et al. | 2006-08-10 |
| Therapeutic heterocyclic compounds Grant 7,045,514 - Pierson , et al. May 16, 2 | 2006-05-16 |
| Therapeutic chromone compounds Grant 7,026,314 - Chapdelaine , et al. April 11, 2 | 2006-04-11 |
| Therapeutic chromone compounds App 20060019947 - Chapdelaine; Marc ; et al. | 2006-01-26 |
| Therapeutic heterocyclic compounds App 20050182050 - Pierson, Edward ; et al. | 2005-08-18 |
| N-type calcium channel antagonists for the treatment of pain Grant 6,906,193 - Ernst , et al. June 14, 2 | 2005-06-14 |
| Therapeutic quinolone compounds with 5-ht-antagonistic properties App 20050096312 - Haeberlein, Markus ; et al. | 2005-05-05 |
| Therapeutic quinolone compounds with 5-ht-antagonistic properties App 20050085457 - Haeberlein, Markus ; et al. | 2005-04-21 |
| Therapeutic heterocyclic compounds App 20050009818 - Pierson, Edward ; et al. | 2005-01-13 |
| N-type calcium channel antagonists for the treatment of pain Grant 6,841,680 - Chapdelaine , et al. January 11, 2 | 2005-01-11 |
| N-type calcium channel antagonists for the treatment of pain Grant 6,815,447 - Chaudhari , et al. November 9, 2 | 2004-11-09 |
| Therapeutic heterocyclic compounds Grant 6,812,225 - Pierson , et al. November 2, 2 | 2004-11-02 |
| Therapeutic chroman compounds App 20040110745 - Chapdelaine, Marc ; et al. | 2004-06-10 |
| Therapeutic chromone compounds App 20040087575 - Chapdelaine, Marc ; et al. | 2004-05-06 |
| Therapeutic heterocyclic compounds App 20040082591 - Chapdelaine, Marc ; et al. | 2004-04-29 |
| N-type calcium channel antagonists for the treatment of pain App 20040077644 - Chapdelaine, Marc ; et al. | 2004-04-22 |
| N-type calcium channel antagonists for the treatment of pain App 20040058945 - Chaudhari, Bipinchandra ; et al. | 2004-03-25 |
| N-type calcium channel antagonists for the treatment of pain App 20040053965 - Chapdelaine, Marc ; et al. | 2004-03-18 |
| N-type calcium channel antagonists for the treatment of pain App 20040053964 - Ernst, Glen ; et al. | 2004-03-18 |
| Therapeutic heterocyclic compounds App 20030013708 - Pierson, Edward ; et al. | 2003-01-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 